The India continuous glucose monitoring devices market size reached USD 240.6 Million in 2025 and is projected to reach USD 359.41 Million by 2034, growing at a CAGR of 4.56% during 2026-2034. Growth is driven by government healthcare expansion programs, integrated diabetes management initiatives, and adoption of advanced CGM solutions featuring Bluetooth connectivity and AI analytics. Strategic partnerships between global and local players further support market expansion. the report offers a comprehensive analysis of the industry, including India continuous glucose monitoring devices market share, trends and regional insights.
STUDY ASSUMPTION YEARS
- Base Year: 2025
- Historical Year/Period: 2020-2025
- Forecast Year/Period: 2026-2034
INDIA CONTINUOUS GLUCOSE MONITORING DEVICES MARKET KEY TAKEAWAYS
- Current Market Size: USD 240.6 Million in 2025
- CAGR: 4.56%
- Forecast Period: 2026-2034
- Government-led healthcare expansion programs and diabetes management initiatives improve access to advanced monitoring technologies.
- Technological advancements include long-lived sensors, factory-calibrated systems, and Bluetooth-enabled devices enhancing user comfort and connectivity.
- Local manufacturing under the Make in India campaign reduces costs, improving affordability and adoption.
- Increasing awareness and integration of CGMs in healthcare and corporate wellness programs drive market penetration.
- Real-time glucose monitoring adoption supports proactive diabetes management and better clinical outcomes.
RECENT DEVELOPMENTS & NEWS
In August 2025, Abbott launched the FreeStyle Libre 2 Plus in India, offering real-time minute-by-minute glucose monitoring with optional alarms, enhancing diabetes management accessibility and boosting market adoption through improved accuracy and connectivity. In June 2025, Tracky introduced India’s first Bluetooth-enabled continuous glucose monitoring device providing real-time, scan-free glucose tracking via a mobile app. This innovation increased accessibility, affordability, and preventive diabetes care, significantly driving market adoption and technological progress.
Request Free Detailed Forecast: https://www.imarcgroup.com/india-continuous-glucose-monitoring-devices-market/requestsample
MARKET TRENDS
Technological advancements and product innovations in the India continuous glucose monitoring devices market focus on long-lived sensors, factory-calibrated systems, and devices with better skin adherence to enhance user comfort. Implantable sensors and minimally intrusive devices have improved adoption rates. Bluetooth-enabled devices allow wireless data transmission to smartphones and healthcare professionals. Cloud data storage and AI analytics enable remote patient monitoring and individualized treatment adjustments. Government digital health initiatives like Ayushman Bharat Digital Mission encourage integration of CGMs with electronic medical records, facilitating seamless diabetes care.
Accessibility and affordability have emerged as key trends fueling CGM device adoption. Initially considered premium, increased local production and competitive pricing are making CGMs accessible to middle-income households. Hospitals, diabetes clinics, telemedicine platforms, and pharmacies promote CGM usage for better treatment adherence. Awareness campaigns educate users on continuous monitoring benefits over periodic testing. Urban and semi-urban demand is strong due to lifestyle-induced diabetes risks. Corporate wellness programs and government chronic disease management initiatives further promote market penetration.
Rising demand for real-time glucose monitoring is a significant growth trend. Unlike traditional finger-prick testing, CGMs provide continuous glucose readings, helping users detect fluctuations and trends. Healthcare providers recommend CGMs to reduce hypoglycemia risks and improve treatment precision. Integration with mobile apps and wearables enhances user-friendliness, with instant alerts facilitating timely interventions. Technology improvements such as longer-lasting sensors and painless insertions combined with AI analytics are shifting diabetes management from reactive to predictive, promising sustainable market growth and improved patient outcomes.
MARKET GROWTH FACTORS
Government-led healthcare expansion programs and integrated diabetes management initiatives are driving market growth by improving access to advanced continuous glucose monitoring technologies. The Make in India campaign’s local manufacturing plans have contributed to cost reduction and greater affordability, while digitization efforts through the Ayushman Bharat Digital Mission promote CGM integration with electronic medical records, facilitating better chronic disease management and patient adherence.
Increased adoption of technologically advanced CGM solutions with features such as Bluetooth connectivity and AI-driven analytics supports market expansion. These innovations enable wireless connectivity, remote monitoring, and personalized treatment adaptation, improving user experience and clinical outcomes. Strategic partnerships between global medical technology companies and local healthcare providers help create solutions tailored for the Indian climate and lifestyle, further enhancing acceptance and usage.
The rising prevalence of Type 1 and Type 2 diabetes in India, coupled with growing awareness about proactive disease management, fuels demand for continuous, real-time glucose monitoring devices. Urbanization and lifestyle changes contribute to heightened diabetes risk. Healthcare providers increasingly recommend CGM devices to reduce hypoglycemia risks and improve treatment accuracy. Insurance companies evaluating coverage options may also encourage broader adoption, supporting sustained market growth.
Explore the Full Report with Charts, Table of Contents, and List of Figures: https://www.imarcgroup.com/india-continuous-glucose-monitoring-devices-market
MARKET SEGMENTATION
Component Insights:
- Sensors: Devices that measure glucose levels continuously and transmit data for monitoring.
- Durables (Receivers and Transmitters): Devices that receive and transmit glucose data for analysis and display.
Regional Insights:
- North India: A major regional market for continuous glucose monitoring devices.
- West and Central India: An important area contributing to the market.
- South India: Significant market region with growing adoption.
- East India: Emerging market region in CGM devices.
REGIONAL INSIGHTS
North India is identified as the dominant region in the India continuous glucose monitoring devices market. The report provides comprehensive analysis of major regional markets including North India, West and Central India, South India, and East India, supporting strategic insights into regional market dynamics and growth opportunities.
KEY PLAYERS
- Abbott
- Tracky
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
ABOUT US
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
CONTACT US
IMARC Group,
134 N 4th St. Brooklyn, NY 11249, USA,
Email: sales@imarcgroup.com,
Tel No: (D) +91 120 433 0800,
United States: +1-201971-6302